Is there a role for autotransplants in patients with follicular lymphoma in the rituximab era?

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Patients with low grad follicular lymphoma were shown to be able to achieve long-term disease-free survival when transplanted after relapse in the era before the wide spread use of rituximab. It appears that the availability of rituximab has not diminished the value of transplantation (i.e., either autologous or allogeneic) in the care of these patients. A similar overall survival and less treatment related toxicity make autologous transplantation the better choice for most patients transplanted at first treatment failure.

Original languageEnglish (US)
Pages (from-to)24-26
Number of pages3
JournalTransfusion and Apheresis Science
Volume49
Issue number1
DOIs
StatePublished - Aug 2013

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Is there a role for autotransplants in patients with follicular lymphoma in the rituximab era?'. Together they form a unique fingerprint.

  • Cite this